437 related articles for article (PubMed ID: 28667742)
21. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
[TBL] [Abstract][Full Text] [Related]
22. Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
Laroche ML; Quelven I; Mazère J; Merle L
Ann Pharmacother; 2015 Jan; 49(1):39-47. PubMed ID: 25366341
[TBL] [Abstract][Full Text] [Related]
23. Pharmacoepidemiology and its input to pharmacovigilance.
Faillie JL; Montastruc F; Montastruc JL; Pariente A
Therapie; 2016 Apr; 71(2):211-6. PubMed ID: 27080840
[TBL] [Abstract][Full Text] [Related]
24. Amiodarone and Parkinsonism: a pharmacovigilance study.
Montastruc JL; Durrieu G
Fundam Clin Pharmacol; 2021 Aug; 35(4):781-784. PubMed ID: 33098706
[TBL] [Abstract][Full Text] [Related]
25. Safety profile of etifoxine: A French pharmacovigilance survey.
Cottin J; Gouraud A; Jean-Pastor MJ; Dautriche AD; Boulay C; Geniaux H; Auffret M; Bernard N; Descotes J; Vial T
Fundam Clin Pharmacol; 2016 Apr; 30(2):147-52. PubMed ID: 26588183
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of adverse drug reactions during two heat waves that occurred in France in 2003 and 2006.
Sommet A; Durrieu G; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):285-8. PubMed ID: 22162094
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
28. [Adverse drug reactions (ADRs) to antimalarial drugs. Analysis of spontaneous report from the French pharmacovigilance database (1996-2000)].
Angles A; Bagheri H; Montastruc JL; Magnaval JF;
Presse Med; 2003 Jan; 32(3):106-13. PubMed ID: 12610379
[TBL] [Abstract][Full Text] [Related]
29. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System.
Nogueira Guerra L; Herdeiro MT; Ribeiro-Vaz I; Clérigo MI; Rocha C; Araújo A; Pêgo A; Rebelo Gomes E
Expert Opin Drug Saf; 2015; 14(12):1805-13. PubMed ID: 26549822
[TBL] [Abstract][Full Text] [Related]
30. [Drugs and retinal disorders: A case/non-case study in the French pharmacovigilance database].
Bourgeois N; Chavant F; Lafay-Chebassier C; Leveziel N; Pérault-Pochat MC
Therapie; 2016 Sep; 71(4):365-74. PubMed ID: 27203167
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced yawning: a review of the French pharmacovigilance database.
Sommet A; Desplas M; Lapeyre-Mestre M; Montastruc JL;
Drug Saf; 2007; 30(4):327-31. PubMed ID: 17408309
[TBL] [Abstract][Full Text] [Related]
32. Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014.
Awodele O; Ibrahim A; Orhii P
Int J Risk Saf Med; 2016 Mar; 28(1):13-23. PubMed ID: 27176753
[TBL] [Abstract][Full Text] [Related]
33. Drug-related hypophosphatemia: Descriptive study and case/non-case analysis of the French national pharmacovigilance database.
Thillard EM; Sade P; Michot J; Bres V; Jonville-Bera AP
Therapie; 2024; 79(3):371-378. PubMed ID: 37634954
[TBL] [Abstract][Full Text] [Related]
34. [Drug-related neuropathies: analysis of the French Adverse Drug Reaction Database 1995-2005].
Durrieu G; Lacroix I; Olivier P; Sommet A; Sénard JM; Montastruc JL;
Presse Med; 2008 Jun; 37(6 Pt 1):935-42. PubMed ID: 18242948
[TBL] [Abstract][Full Text] [Related]
35. Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
Kheloufi F; Default A; Rouby F; Laugier-Castellan D; Boyer M; Rodrigues B; Ponte-Astoul J; Jean-Pastor MJ; Blin O; Micallef J
Eur J Clin Pharmacol; 2017 Aug; 73(8):1009-1018. PubMed ID: 28391408
[TBL] [Abstract][Full Text] [Related]
36. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
Bondon-Guitton E; Sommet A; Montastruc JL;
Pharmacopsychiatry; 2009 Mar; 42(2):61-5. PubMed ID: 19308880
[TBL] [Abstract][Full Text] [Related]
37. Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database.
Chavant F; Favrelière S; Lafay-Chebassier C; Plazanet C; Pérault-Pochat MC
Br J Clin Pharmacol; 2011 Dec; 72(6):898-904. PubMed ID: 21557759
[TBL] [Abstract][Full Text] [Related]
38. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
39. Detection of adverse drug reactions: evaluation of an automatic data processing applied in oncology performed in the French Diagnosis Related Groups database.
Quillet A; Colin O; Bourgeois N; Favrelière S; Ferru A; Boinot L; Lafay-Chebassier C; Perault-Pochat MC
Fundam Clin Pharmacol; 2018 Apr; 32(2):227-233. PubMed ID: 29143369
[TBL] [Abstract][Full Text] [Related]
40. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.
Faillie JL; Babai S; Crépin S; Bres V; Laroche ML; Le Louet H; Petit P; Montastruc JL; Hillaire-Buys D;
Acta Diabetol; 2014; 51(3):491-7. PubMed ID: 24352344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
